| 1. |
Pancharoen C, Mekmullica J, Chinratanapisit S, Bhattarakosol P, Thisyakorn U. Seroprevalence of Epstein-Barr virus antibody among children in various age groups in Bangkok, Thailand. Asian Pac J Allergy Immunol 2001;19(2):135-7. |
| 2. |
Pancharoen C, Bhatrarakosol P, Thisyakorn U. Seroprevalence of Epstein-Barr virus infection in Thai children. J Med Assoc Thai 2001;84(6):850-4. |
| 3. |
Poovorawan Y, Tantimongkolsuk C, Chongsrisawat V, Theamboonlers A. High prevalence of Epstein-Barr virus antibody among school children of the low to middle socio-economic class in Bangkok, Thailand. Southeast Asian J Trop Med Public Health 1997;28(2):434-5. |
| 4. |
Babcock GJ, Decker LL, Volk M, Thorley-Lawson DA. EBV persistence in memory B cells in vivo. Immunity 1998;9(3):395-404. |
| 5. |
Sumaya CV. Endogenous reactivation of Epstein-Barr virus infections. J Infect Dis 1977;135(3):374-9. |
| 6. |
Aalto SM, Linnavuori K, Peltola H, Vuori E, Weissbrich B, Schubert J, et al. Immunoreactivation of Epstein-Barr virus due to cytomegalovirus primary infection. J Med Virol 1998;56(3):186-91. |
| 7. |
Okano M, Gross TG. Epstein-Barr virus-associated hemophagocytic syndrome and fatal infectious mononucleosis. Am J Hematol 1996;53(2):111-5. |
| 8. |
Schooley RT. Epstein-Barr Virus (Infectious Mononucleosis). In: Mandell GL, Bennett JE, Dolin R, editors. Principles and Practice of Infectious Diseases. 5th ed. Philadelphia: Churchill Livingstone; 2000. p. 1599-1613. |
| 9. |
Sayos J, Wu C, Morra M, Wang N, Zhang X, Allen D, et al. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM. Nature 1998;395(6701):462-9. |
| 10. |
Cohen JI. Epstein-Barr virus infection. N Engl J Med 2000;343(7):481-92. |
| 11. |
Kimura H, Hoshino Y, Kanegane H, Tsuge I, Okamura T, Kawa K, et al. Clinical and virologic characteristics of chronic active Epstein-Barr virus infection. Blood 2001;98(2):280-6. |
| 12. |
Kasahara Y, Yachie A, Takei K, Kanegane C, Okada K, Ohta K, et al. Differential cellular targets of Epstein-Barr virus (EBV) infection between acute EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection. Blood 2001;98(6):1882-8. |
| 13. |
Quintanilla-Martinez L, Kumar S, Fend F, Reyes E, Teruya-Feldstein J, Kingma DW, et al. Fulminant EBV(+) T-cell lymphoproliferative disorder following acute/chronic EBV infection: a distinct clinicopathologic syndrome. Blood 2000;96(2):443-51. |
| 14. |
McClain KL, Leach CT, Jenson HB, Joshi VV, Pollock BH, Parmley RT, et al. Association of Epstein-Barr virus with leiomyosarcomas in children with AIDS. N Engl J Med 1995;332(1):12-8. |
| 15. |
Reyes C, Abuzaitoun O, De Jong A, Hanson C, Langston C. Epstein-Barr virus-associated smooth muscle tumors in ataxia- telangiectasia: A case report and review. Hum Pathol 2002;33(1):133-6. |
| 16. |
Vidrih JA, Walensky RP, Sax PE, Freedberg KA. Positive Epstein-Barr virus heterophile antibody tests in patients with primary human immunodeficiency virus infection. Am J Med 2001;111(3):192-4. |
| 17. |
Tsaparas YF, Brigden ML, Mathias R, Thomas E, Raboud J, Doyle PW. Proportion positive for Epstein-Barr virus, cytomegalovirus, human herpesvirus 6, Toxoplasma, and human immunodeficiency virus types 1 and 2 in heterophile-negative patients with an absolute lymphocytosis or an instrument-generated atypical lymphocyte flag. Arch Pathol Lab Med 2000;124(9):1324-30. |
| 18. |
Linde A. Diagnosis of Epstein-Barr virus-related diseases. Scand J Infect Dis Suppl 1996;100:83-8. |
| 19. |
Weissbrich B. The use of semi-automated EBV IgG avidity determination for the diagnosis of infectious mononucleosis. J Med Virol 1998;54(2):145-53. |
| 20. |
Miller G, Grogan E, Rowe D, Rooney C, Heston L, Eastman R, et al. Selective lack of antibody to a component of EB nuclear antigen in patients with chronic active Epstein-Barr virus infection. J Infect Dis 1987;156(1):26-35. |
| 21. |
van der Horst C, Joncas J, Ahronheim G, Gustafson N, Stein G, Gurwith M, et al. Lack of effect of peroral acyclovir for the treatment of acute infectious mononucleosis. J Infect Dis 1991;164(4):788-92. |
| 22. |
Tynell E, Aurelius E, Brandell A, Julander I, Wood M, Yao QY, et al. Acyclovir and prednisolone treatment of acute infectious mononucleosis: a multicenter, double-blind, placebo-controlled study. J Infect Dis 1996;174(2):324-31. |
| 23. |
Straus SE, Cohen JI, Tosato G, Meier J. NIH conference. Epstein-Barr virus infections: biology, pathogenesis, and management. Ann Intern Med 1993;118(1):45-58. |
|
